Targeting LAT1 Transporter Suppresses Cancer Cells by Depleting Valine and Isoleucine
Researchers have discovered that inhibiting the amino acid transporter LAT1 suppresses cancer cell growth and impairs mitochondrial energy metabolism primarily ...
Researchers have discovered that inhibiting the amino acid transporter LAT1 suppresses cancer cell growth and impairs mitochondrial energy metabolism primarily ...
A scientific review evaluates evidence on how cytomegalovirus may influence cancer stem cells and therapy resistance while noting that tumor ...
A study integrating single-cell sequencing and Mendelian randomization identified CTSH, MUC1, and SLBP as candidate genes associated with regulatory pathways ...
A narrative review synthesises the cellular mechanisms, genetic engineering approaches, preclinical models, and clinical translation barriers of oncolytic virotherapy across ...
An experimental tumor-targeted TGF-β blocker cleared aggressive cancers in mice and stimulated durable immune memory across multiple solid tumor types.
In preclinical models, combining agrimoniin with erlotinib inhibited pancreatic cancer cell proliferation by altering tumor microenvironment signaling and disrupting metabolic ...
A new study shows that blocking the enzyme complement factor B with iptacopan halts pancreatic cancer growth and reshapes the ...
A review in Microbial Ecology details how nutritional abnormalities and gut microbiota dysbiosis interact in pancreatic ductal adenocarcinoma, influencing disease ...
A study in Cancer & Metabolism reveals that ferroptosis in tumor cells promotes an immunosuppressive microenvironment in mouse models, outweighing ...
Elevated tissue stiffness in pancreatic cancer activates YAP–RUNX1 signaling to drive helper T cell dysfunction and tumor immunosuppression.
Researchers discover that inhibiting the splicing regulator SRRM1 activates ferroptosis to overcome gemcitabine resistance in pancreatic cancer models.
A review in Cell Division evaluates AI and machine learning models for pancreatic cancer diagnosis, highlighting their high reliability in ...
Researchers have identified distinct tumor molecular signatures and immune cell profiles in pancreatic cancer between Black African American and Non-African ...
A new review in Cell Communication and Signaling examines how three forms of regulated cell death interact in pancreatic ductal ...
A new review maps how nerve, immune and tumor cell interactions drive pancreatic cancer progression, immune evasion, pain and treatment ...
A new study shows that tumor heterogeneity significantly impacts the success of STING and LTβR-mediated tertiary lymphoid structure induction in ...
A new review maps how the three secreted FGFBP proteins tune FGF signaling in physiology and act as divergent prognostic ...
A new study shows that the metabolic peptide Adropin promotes glycolytic reprogramming and EMT in pancreatic cancer through β₂-adrenergic receptor, ...
Cancer-associated fibroblasts deliver blood-borne cholesterol to pancreatic cancer cells and suppress T cell function through ANO6-dependent trogocytosis, a contact-based membrane ...
A Japanese case series found that 83 percent of selected patients with advanced pancreatic cancer showed marked histopathological tumor regression ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.